BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
35 hedge funds and large institutions have $7.11M invested in BRAINSTORM CELL THERAPUTC in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.07% more ownership
Funds ownership: 0.58% → 0.64% (+0.07%)
41% less call options, than puts
Call options by funds: $80K | Put options by funds: $135K
Holders
35
Holding in Top 10
–
Calls
$80K
Puts
$135K
Top Buyers
| 1 | +$359K | |
| 2 | +$296K | |
| 3 | +$208K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$69.4K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$31K |
Top Sellers
| 1 | -$206K | |
| 2 | -$68K | |
| 3 | -$57K | |
| 4 |
VF
Virtu Financial
New York
|
-$52K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.88K |